3
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular Agents (Including Blood Products)

Patent Evaluation: Novel Piperidines as Anti-arrhythmic Agents

Pages 943-944 | Published online: 02 Mar 2011
 

Summary

Novelty: Piperidine derivatives, which are said to have potential utility as anti-arrhythmic agents, are disclosed.

Biology: An in vivo rodent study is described. Test compounds were administered (ip) thirty minutes before deep chloroform anaesthesia-induced arrhythmia. The most active compound was found to have a minimum effective (anti-arrhythmic) dose of 25 mg/kg.

Chemistry: 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(N-imidazolylmethyl)cinn amyl]-piperidine is one of one hundred and fifteen exemplified compounds. Preparative details using standard techniques are presented.

Structure:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.